## ğŸ“ Research Question / Hypothesis | ç ”ç©¶å•é¡Œ/å‡è¨­

### Primary Question | ä¸»è¦ç ”ç©¶å•é¡Œ
> [State your primary research question]

### Hypothesis | å‡è¨­
> [State your hypothesis if applicable]

---

## ğŸ“ Study Design | ç ”ç©¶è¨­è¨ˆ

**Design Type**: [RCT / Cohort / Cross-sectional / Case-control / etc.]

### Randomization (if applicable)
> [Describe randomization method]

### Blinding (if applicable)
> [Single / Double / None - describe]

---

## ğŸ“ Participants | ç ”ç©¶å°è±¡

### Inclusion Criteria | ç´å…¥æ¢ä»¶
-
-
-

### Exclusion Criteria | æ’é™¤æ¢ä»¶
-
-
-

### Sample Size | æ¨£æœ¬æ•¸
- **Target N**:
- **Power calculation**:
- **Expected dropout**:

---

## ğŸ“ Intervention / Exposure | ä»‹å…¥/æš´éœ²

### Intervention Group | ä»‹å…¥çµ„
> [Describe the intervention]

### Control Group | å°ç…§çµ„
> [Describe the control/comparison]

---

## ğŸ“ Outcomes | çµæœæŒ‡æ¨™

### Primary Outcome | ä¸»è¦çµæœ
- **Variable**:
- **Measurement method**:
- **Timing**:

### Secondary Outcomes | æ¬¡è¦çµæœ
1.
2.
3.

---

## ğŸ“ Statistical Analysis | çµ±è¨ˆåˆ†æ

### Primary Analysis | ä¸»è¦åˆ†æ
> [Describe main statistical approach]

### Sensitivity Analysis | æ•æ„Ÿåº¦åˆ†æ
> [Describe planned sensitivity analyses]

### Missing Data Handling | ç¼ºå¤±å€¼è™•ç†
> [Describe approach to missing data]

---

## ğŸ“ Ethical Considerations | å€«ç†è€ƒé‡

- **IRB Approval**: [Status / Number]
- **Informed Consent**: [Process description]
- **Data Protection**: [GDPR / HIPAA compliance]
- **Trial Registration**: [ClinicalTrials.gov / etc.]
